null Skip to main content

Semaglutide May Reduce The Risk Of Some Cancers By 65%

Aug 21st 2024

Information provided on this website is for initial reference. The website and/or this blog do not provide medical advice, and we do not warrant the accuracy of the information. If you have any questions or concern, contact us or your current physician. For more information, please see below.

Are you concerned about developing obesity related cancers?

Unfortunately, unhealthy weight and obesity can lead to multiple types of cancer and related death. Semaglutide may substantially reduce your risk of developing cancer, in addition to helping you lose weight.


In July of 2024, the Journal of the American Medical Association published a new and significant study providing evidence that people with type 2 diabetes, who take semaglutide, may be less likely to develop certain forms of cancer.


The study, which pulled from the medical data of 1,651,452 patients across 13 years, compared those with type 2 diabetes who had been prescribed a GLP-1, insulin, or metformin. The study found people taking semaglutide had less risk of developing 10 of these obesity-associated cancers, including esophageal, colorectal, endometrial, gallbladder, kidney, liver, ovarian, pancreatic cancer, meningioma and multiple myeloma.


Although more research and trials are needed, the research team found that people with type 2 diabetes on GLP-1 drugs compared to those on insulin had reduced risk of multiple cancers including the following:


65% reduced risk of gallbladder cancer 63% reduced risk of meningioma

59% reduced risk of pancreatic cancer

53% reduced risk of a type of liver cancer called hepatocellular carcinoma

48% reduced risk of ovarian cancer 46% reduced risk of colorectal cancer

41% reduced risk of multiple myeloma 40% reduced risk of esophageal cancer

26% reduced risk of endometrial cancer 24% reduced risk of kidney cancer


Let us help you lose weight, and help reduce your risk of cancer.

Some information on the site is written by eesi.com and/or affiliates, and some content is provided by outside sources.

The content of this blog, website, such as graphics, images, text and all other materials, is provided for initial reference only. The content is for discussion purposes and is not meant to be complete or to be applicable to any specific individual's medical condition. In addition, eesi.com assumes no duty to correct or update the blog or website nor to resolve or clarify any inconsistent information that might be a part of the website.

The content on this website is not intended to be a substitute for professional medical advice, diagnosis or treatment. Further, the content is not an attempt to practice medicine or provide specific medical advice, and it should not be used to make a diagnosis or to replace or circumvent a qualified health care provider's judgment. Always consult with a qualified and licensed physician or other medical care provider, and follow their advice without delay regardless of anything you read on this website. If you are seeing a medical doctor, you should ask that physician directly with any questions. If you wish to seek medical advice, you must fully register and complete the checkout process for our partner physician to review. You will receive confirmation when this is complete. In that case ONLY, the information you submit will be used to arrange for care where and when appropriate. You assume full and complete responsibility for using the information on this website, and you understand and agree that eesi.com and its affiliates, including partner physician and pharmacy are not responsible or liable for any claim, loss or damage resulting from its use by you or any user.